secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ensysce Biosciences, Inc. (ENSC)
CIK:        0001716947
Form:       8-K
Filed at:   2025-04-24T23:59:59+00:00
Accession:  0001641172-25-006009
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ensysce raises $2.2M via warrant exercise inducement; issues new warrants for 1.26M shares
--------------------------------------------------------------------------------

- Holders exercised 630,376 warrants at $3.24/share for cash; gross proceeds ~$2.2M before fees.
- Company issued new unregistered warrants to purchase 1,260,752 shares at $1.90, split 18-month and 5-year terms.
- Net proceeds ~$1.9M to fund TAAP and MPAR programs and working capital.
- H.C. Wainwright acted as placement agent; received 7% cash fee and 44,126 agent warrants at $4.05.
- New warrants include 4.99% beneficial ownership limitation (9.99% at holder election).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716947/000164117225006009/0001641172-25-006009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716947/000164117225006009/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-006009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer